Larvol Delta - First-participant-treated-at-the-highest-dose-level-in-Clarity39s-theranostic-prostate-cancer-trial

64/67Cu SAR-bisPSMA theranostic - Clarity Pharma

https://www.prnewswire.com/news-releases/first-participant-treated-at-the-highest-dose-level-in-claritys-theranostic-prostate-cancer-trial-301909746.html

Aug 25, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next